For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251002:nRSB8675Ba&default-theme=true
RNS Number : 8675B Baillie Gifford US Growth Trust PLC 02 October 2025
For immediate release
Baillie Gifford US Growth Trust plc ("USA" or the "Company")
Legal Entity Identifier: 213800UM1OUWXZPKE539
Result of Annual General Meeting
2 October 2025
USA announces the results of its Annual General Meeting, held today, Thursday
2 October 2025, at the offices of Baillie Gifford & Co (Calton Square, 1
Greenside Row, Edinburgh EH1 3AN).
All ordinary resolutions as set out in the Notice of AGM were duly passed by
poll, together with the special resolution numbered 12 (regarding the
authority to repurchase shares).
The special resolution numbered 11 (regarding the disapplication of
pre-emption rights) did not pass.
While resolutions 2, 4, 5, 6, 7 and 10 passed, they received a significant
number of votes against. The Board notes that the significant votes against
were almost entirely attributable to a single shareholder. Excluding this
position, the vast majority of other shareholders voted in favour, which the
Board considers to be a clear indication of support for the Company.
In line with Provision 4 of section 5.2 of the AIC Corporate Governance Code
2024, the Company will now engage in a consultation process with all major
shareholders. The Board is committed to taking the views of all shareholders
into account and will give careful consideration to all views received. The
Board will report on next steps as soon as is practicable and certainly within
the six months timeframe set out in the AIC Code.
Tom Burnet, Chair of the Company commented:
"Following both the Requisitioned General Meeting in February and the annual
results in August, we engaged with a range of institutional shareholders for
their views on our strategy, with all major shareholders being offered
meetings with the Senior Independent Director and myself. These meetings were
useful and productive, and we were grateful for shareholders' feedback and
support.
"Saba Capital, the Company's largest shareholder, rejected our offer of a
meeting following the annual results. Whilst we recognise their right to
exercise their democratic vote, it is disappointing that Saba, without prior
notice of their intention, should use their substantial holding to attempt to
vote off the whole Board of Directors. Had they succeeded, without Directors
the Company would have been in breach of the Companies Act, the UK Listing
Rules and its own Articles, which would have had significant consequences for
all shareholders.
"We will again seek to engage with Saba to understand their position. The
Board remains committed to acting in the interests of shareholders as a
whole."
Results of poll
Ordinary Resolutions VOTES FOR VOTES AGAINST VOTES WITHHELD TOTAL VOTING RIGHTS EXERCISED
(including votes at the discretion of the Chair)
Number % Number % Number %
1. To receive and adopt the Annual Report and Financial Statements of 163,429,411 99.98 31,179 0.02 92,657 58.92
the Company for the financial year ended 31 May 2025 together with the Reports
of the Directors and of the Independent Auditor thereon.
2. To approve the Directors' Remuneration Policy. 85,955,420 52.59 77,490,638 47.41 107,189 58.91
3. To approve the Directors' Annual Report on Remuneration for the 163,263,910 99.90 165,227 0.10 124,110 58.90
financial year ended 31 May 2025.
4. To re-elect Mr TJW Burnet as a Director of the Company. 83,872,121 51.33 79,537,554 48.67 143,572 58.90
5. To re-elect Ms SP Inglis as a Director of the Company. 84,522,062 51.72 78,888,033 48.28 143,152 58.90
6. To re-elect Mr GD Paterson as a Director of the Company. 84,552,137 51.74 78,850,107 48.26 151,003 58.89
7. To re-elect Mr CRD van der Kuyl as a Director of the Company. 84,548,923 51.74 78,848,354 48.26 155,970 58.89
8. To re-appoint Ernst & Young LLP as Independent Auditor of the 163,382,285 99.95 77,033 0.05 93,929 58.92
Company to hold office until the conclusion of the next Annual General Meeting
at which the Financial Statements are laid before the Company.
9. To authorise the Directors to determine the remuneration of the 163,372,324 99.95 84,063 0.05 96,860 58.91
Independent Auditor of the Company.
10. To authorise the Directors' general authority to allot shares or C 85,999,504 52.62 77,449,142 47.38 104,601 58.91
shares.
Special Resolutions
11. To approve by special resolution that the Directors be authorised to 84,722,147 52.20 77,583,536 47.80 71,762 58.50
allot shares, C shares or sell treasury shares on a non pre-emptive basis.
12. To approve by special resolution that the Company be authorised to make 162,281,535 99.98 39,853 0.02 56,057 58.51
market purchases of its own shares.
The full text of all the resolutions can also be found in the Notice of Annual
General Meeting which is available for viewing at the National Storage
Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
Enquiries:
Company
Tom Burnet
c/o Burson Buchanan
USA@buchanancomms.co.uk
+44 (0)20 7466 5000
Panmure Liberum Limited
Alex Collins / Michael Janes
info@panmureliberum.com
+44 (0)20 3100 2000
Burson Buchanan
Henry Wilson / Helen Tarbet / Nick Croysdill
USA@buchanancomms.co.uk
+44 (0)20 7466 5000
Company Secretary
Baillie Gifford & Co Limited, Company Secretary
trustenquiries@bailliegifford.com
+44 (0)800 917 2113
Regulated Information Classification: Additional regulated information
required to be disclosed under applicable laws and regulations.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGUUSURVOURRAA